Asthma and COPD Drugs Market is expected to reach US$ 82.2 Billion by 2036, driven by Advancements in Drug Discovery and ...

UK pharma major GSK’s Nucala (mepolizumab) has recently received approval in China as add-on maintenance treatment for adults ...

Temple Health is testing a tiny, flexible scaffold aimed at relieving a common problem for emphysema patients: overinflation ...

GSK has high hopes for Nucala thanks to its less frequent dosing – once a month, versus every other week for Dupixent – and the broader label. The company has estimated that among people with COPD who ...

Recently, rumors have been swirling online that Landman star Sam Elliott has Chronic Obstructive Pulmonary Disease (COPD). Some people even claim to have seen the 81-year-old actor promoting a ...

Washington is once again debating whether to pour more taxpayer dollars into Obamacare subsidies. But for millions of Americans struggling ...

The MHRA has authorised GSK’s Nucala (mepolizumab) in the UK as an add‑on maintenance treatment for adults with uncontrolled COPD of an eosinophilic phenotype who are already receiving triple therapy ...

If you often feel short of breath when you talk, walk a short distance, or use the stairs, you might think it is just a ...

Select your location to view local American Lung Association events and news near you.

AirNexis has handed over $40 million cash for Haisco’s HSK39004, coded by AirNexis as AN01. Under the terms of the deal, ...

Delaware-based AirNexis will develop, produce, and commercialize HSK39004, a dual inhibitor that can improve airflow ...

Respiratory and sleep medicine physicians share collaborative measures to diagnose and treat comorbid sleep disorders and ...